Saturday 17 October 2026
Export MCTA’s income statement to Excel — free account
Charming Medical Limited
MCTA Healthcare Medical Care Facilities
Charming Medical Limited’s revenue for fiscal 2026 (year ended March 2026) was $4.8 million, down 22.7% from fiscal 2025.
29.36
0.00
0.00%
Follow MCTA
| Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|
Piotroski F-Score |
— | — | 2 |
Altman Z-Score |
— | — | 61.64 |
Altman Z″-Score (non-manufacturers) |
(2.50) | (0.11) | 3.73 |
Beneish M-Score |
— | (1.97) | (2.49) |
P/B ratio |
0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 |
EV/FCF |
0.00 | 0.00 | 0.00 |
Quick Ratio |
0.57 | 0.64 | 1.56 |
Current Ratio |
0.62 | 0.68 | 1.89 |
Net Debt/EBITDA |
(1.17) | (1.42) | (34.00) |
Debt/Assets |
9.45% | 7.74% | 1.88% |
Debt/Equity |
(0.40) | 8.42 | 0.04 |
Asset Turnover |
0.00 | 1.22 | 0.63 |
Operating CF/Net income |
0.38 | 0.36 | 53.80 |
Capex/Depreciation |
(0.54) | (1.09) | (1.43) |
Interest Coverage |
38.65 | 66.45 | (1.85) |
| 0.00% | (218.63%) | (0.86%) | |
| 0.00% | 23.43% | (0.30%) | |
ROIC |
0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(44.63%) | (110.90%) | (0.51%) |
Average Days of Receivables |
75.04 | 23.23 | 15.30 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
52.73% | 52.59% | 61.86% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | — |
Free Cash Flow per Share |
0.01 | 0.01 | (0.09) |
Cash per Share |
0.14 | 0.18 | 0.40 |
Shareholders Equity per Share |
(0.07) | 0.00 | 0.32 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(0.07) | 0.00 | 0.32 |
Free Cash Flow |
0.08 | 0.14 | (1.52) |
Working Capital |
(2.21) | (1.58) | 3.84 |
Capital Expenditures |
(0.21) | (0.29) | (0.31) |
Net Current Asset Value |
(2.36) | (1.94) | 3.49 |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.04 | 0.05 | 0.06 |
| Other line items | |||
Depreciation/Fixed assets |
0.83 | 0.53 | 0.36 |
Cash ROIC |
5.98% | 4.29% | (12.81%) |
Accounts Receivable Turnover |
0.00 | 7.62 | 16.10 |
Accounts Payable Turnover |
0.00 | 0.04 | 0.11 |
Inventory Turnover |
0.00 | 0.56 | 1.34 |
Average Days of Payables |
14,574.16 | 5,804.68 | 4,306.38 |
Days of Inventory on Hand |
910.89 | 631.10 | 265.45 |
Revenue per Share |
0.39 | 0.41 | 0.30 |
Operating CF per Share |
0.02 | 0.03 | (0.08) |
Capex per Share |
(0.01) | (0.02) | (0.02) |
Average Receivables |
— | 0.82 | 0.30 |
Average Payables |
— | 0.35 | 0.33 |
Average Inventory |
— | 0.03 | 0.03 |
Average Assets |
— | 5.12 | 7.61 |
Average Common Equity |
— | (0.55) | 2.62 |
Columns are period end dates · fundamentals updated 12 Oct 2026